Cyclin C nuclear release and mitochondrial dysfunction define molecular signatures of MED13L syndrome.

Campbell AN, Jung KN, Doyle SJ, Lebayle E, Corneo B, Feng J, Ricupero CL, Bain JM, Strich R

Open source

DOI
10.1016/j.xhgg.2026.100670
Published
2026 Sep 4
Container
HGG advances
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.xhgg.2026.100670,
  title = {Cyclin C nuclear release and mitochondrial dysfunction define molecular signatures of MED13L syndrome.},
  author = {Campbell AN and Jung KN and Doyle SJ and Lebayle E and Corneo B and Feng J and Ricupero CL and Bain JM and Strich R},
  year = {2026},
  journal = {HGG advances},
  doi = {10.1016/j.xhgg.2026.100670},
  url = {https://doi.org/10.1016/j.xhgg.2026.100670}
}

RIS

TY  - JOUR
TI  - Cyclin C nuclear release and mitochondrial dysfunction define molecular signatures of MED13L syndrome.
AU  - Campbell AN
AU  - Jung KN
AU  - Doyle SJ
AU  - Lebayle E
AU  - Corneo B
AU  - Feng J
AU  - Ricupero CL
AU  - Bain JM
AU  - Strich R
PY  - 2026
JO  - HGG advances
DO  - 10.1016/j.xhgg.2026.100670
UR  - https://doi.org/10.1016/j.xhgg.2026.100670
ER  - 

APA

AN, C., KN, J., SJ, D., E, L., B, C., J, F., CL, R., JM, B., & R, S. (2026). Cyclin C nuclear release and mitochondrial dysfunction define molecular signatures of MED13L syndrome.. HGG advances. https://doi.org/10.1016/j.xhgg.2026.100670

Source records